Zhuhai Rundu Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002923.SZ

Zhuhai Rundu Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 0.54

Zhuhai Rundu Pharmaceutical Co., Ltd. Revenue Per Share is USD 0.54 for the year ending December 31, 2023, a -8.39% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Zhuhai Rundu Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 0.59, a 6.13% change year over year.
Zhuhai Rundu Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.56, a -2.58% change year over year.
Zhuhai Rundu Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.57, a -2.69% change year over year.
Zhuhai Rundu Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.59, a 27.39% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shenzhen Stock Exchange: 002923.SZ

Zhuhai Rundu Pharmaceutical Co., Ltd.

CEO	Mr. Jie Liu
IPO Date	Jan. 5, 2018
Location	China
Headquarters	No. 6, North Airport Road
Employees	1,945
Sector	Health Care
Industries Pharmaceuticals

Description

Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical company, develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, CNS, and anesthesia areas in China and internationally. It offers APIs, intermediates, FDF, and pellets, as well as formulations in the forms of capsules, tablets, and injections. The company was founded in 1997 and is headquartered in Zhuhai, China.

Key trends

Past 5 years